Eureka Forbes Limited
Eureka Forbes Limited Fundamental Analysis
Eureka Forbes Limited (EUREKAFORBE.BO) shows weak financial fundamentals with a PE ratio of 110.86, profit margin of 7.22%, and ROE of 2.00%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 34.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze EUREKAFORBE.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakEUREKAFORBE.BO struggles to generate sufficient returns from assets.
Valuation Score
WeakEUREKAFORBE.BO trades at a premium to fair value.
Growth Score
WeakEUREKAFORBE.BO faces weak or negative growth trends.
Financial Health Score
ModerateEUREKAFORBE.BO shows balanced financial health with some risks.
Profitability Score
WeakEUREKAFORBE.BO struggles to sustain strong margins.
Key Financial Metrics
Is EUREKAFORBE.BO Expensive or Cheap?
P/E Ratio
EUREKAFORBE.BO trades at 110.86 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, EUREKAFORBE.BO's PEG of 9.03 indicates potential overvaluation.
Price to Book
The market values Eureka Forbes Limited at 2.22 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 0.00 times EBITDA. This is generally considered low.
How Well Does EUREKAFORBE.BO Make Money?
Net Profit Margin
For every $100 in sales, Eureka Forbes Limited keeps $7.22 as profit after all expenses.
Operating Margin
Core operations generate 33.67 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $2.00 in profit for every $100 of shareholder equity.
ROA
Eureka Forbes Limited generates $0.00 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $0.00 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
110.86
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
9.03
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.22
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.00
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.02
vs 25 benchmark
ROA
Return on assets percentage
0.00
vs 25 benchmark
ROCE
Return on capital employed
0.00
vs 25 benchmark
How EUREKAFORBE.BO Stacks Against Its Sector Peers
| Metric | EUREKAFORBE.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 110.86 | 24.97 | Worse (Expensive) |
| ROE | 2.00% | 1167.00% | Weak |
| Net Margin | 7.22% | 673.00% | Weak |
| Debt/Equity | 0.00 | 0.66 | Strong (Low Leverage) |
| Current Ratio | 0.00 | 4.01 | Weak Liquidity |
| ROA | 0.00% | -8477.00% (disorted) | Weak |
EUREKAFORBE.BO outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Eureka Forbes Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Growth, Discretionary
EPS CAGR
N/A
Industry Style: Cyclical, Growth, Discretionary
FCF CAGR
N/A
Industry Style: Cyclical, Growth, Discretionary